...
首页> 外文期刊>Trends in Ecology & Evolution >Comparing in-patient extracorporeal cardiopulmonary resuscitation to standard cardiac treatment group of extracorporeal membrane oxygenation patients: 8 years of experience at a single institution
【24h】

Comparing in-patient extracorporeal cardiopulmonary resuscitation to standard cardiac treatment group of extracorporeal membrane oxygenation patients: 8 years of experience at a single institution

机译:与体外膜氧合患者标准心脏治疗组的患者体外心肺复苏比较:在单一机构的8年经验

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Post-cardiac arrest survivals remain low despite the effort of cardiopulmonary resuscitation. Utilization of extracorporeal membrane oxygenation during cardiopulmonary resuscitation (extracorporeal cardiopulmonary resuscitation) can provide immediate cardiovascular support and potentially improve outcomes of patients with cardiac arrest requiring cardiopulmonary resuscitation. There is renewed interest in the use of extracorporeal cardiopulmonary resuscitation due to improved outcomes over the years. Methods: Extracorporeal membrane oxygenation data between 2010 and 2018 were reviewed. Patients with extracorporeal membrane oxygenation placed under cardiopulmonary resuscitation were identified, and demographics, extracorporeal membrane oxygenation survival, survival to discharge, and neurological recovery were retrospectively analyzed with institutional review board approval. Results: Among 230 cases of extracorporeal membrane oxygenation, 34 (21 males and 13 females, age of 49 +/- 13 years) underwent extracorporeal cardiopulmonary resuscitation. The mean duration of extracorporeal membrane oxygenation support after extracorporeal cardiopulmonary resuscitation was 8.3 +/- 7.9 days. Extracorporeal membrane oxygenation mortality among extracorporeal cardiopulmonary resuscitation patients was 32% (11/34) and hospital survival was 38% (13/34), which are similar to standard cardiac extracorporeal membrane oxygenation (extracorporeal membrane oxygenation survival 62% and hospital survival 39% in cardiac extracorporeal membrane oxygenation). Among the extracorporeal membrane oxygenation death after extracorporeal cardiopulmonary resuscitation, the majority was due to neurological injury (73%, 8/11); 8/34 extracorporeal membrane oxygenation survival rate and 30-day survival rate were 63% and 25% in early half of study (2010-2014) and have improved to 70% and 60% in late half of study (2014-2018). Conclusion: Over years of experience with extracorporeal membrane oxygenation, the outcome of the extracorporeal cardiopulmonary resuscitation has been improving and appears to exceed those of traditional methods, despite limited sample size. Neurological complications still need to be addressed in order for survival and outcomes to improve.
机译:简介:尽管有心肺复苏的努力,心脏病后逮捕幸存者仍然很低。在心肺复苏期间使用体外膜氧合(体外心肺复苏)可以立即提供内心血管载体,并且可能改善心脏骤停的患者的结果需要心肺复苏。由于多年来改善的结果,对使用体外心肺复苏的使用重新进行了兴趣。方法:综述了2010年和2018年的体外膜氧气数据。鉴定了患有体外膜氧合的患者,并鉴定了人口统计学,体外膜氧化存活,排出的存活和神经恢复,并考虑了机构审查委员会批准。结果:230例体外膜氧合,34例(21名男性和13名女性,49岁+/- 13岁)的体外心肺复苏。体外心肺复扫后体外膜氧合载体的平均持续时间为8.3 +/- 7.9天。体外心肺复苏患者的体外膜氧化死亡率为32%(11/34),医院存活率为38%(13/34),类似于标准心脏体外膜氧合(体外膜氧合生存62%和医院存活39%在心脏体外膜氧合中)。在体外心肺复苏后体外膜氧气死亡中,大多数是由于神经系统损伤(73%,8/11); 8/34体外膜氧化存活率和30天的存活率为63%,初期的研究(2010-2014)初期为63%和25%,并在研究后的一半(2014-2018)中提高了70%和60%。结论:多年来多年体外膜氧合的经验,体外心肺复苏的结果已经改善,似乎超过了传统方法的样本量有限。为了提高生存和结果,需要解决神经系统并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号